R & D systems INC:1107462 - recombinant human ubiquitin rhodamine 110, CF, custom size: 4 X 1MG
Ended Awarded
- Contract number
- HHSN31900004
- Awardee
-
Research And Diagnostic Systems, Inc. UEI WAYSQU5HJYT9 Part of Bio-Techne Corporation
- Awarding agency
-
National Center for Advancing Translational Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $13,204
Award facts
- Contract value 100% obligated
- $13,204.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Minneapolis, MN 55413, USA
Award details come from SAM.gov/FPDS.
About this award
Research and Diagnostic Systems, Inc. (R&D Systems), a Minneapolis-based subsidiary of Bio-Techne Corporation, was awarded a firm fixed price call under its existing Blanket Purchase Agreement (BPA) with the National Center for Advancing Translational Sciences (NCATS) on May 20, 2015. The contract, valued at $13,204, is for the provision of recombinant human ubiquitin rhodamine 110 conjugate in a custom size of four 1-milligram units. This award was made without a set-aside designation, indicating open competition. The work is to be performed in Minneapolis, Minnesota, with an ultimate completion date of August 31, 2015.
R&D Systems has established itself as a critical supplier to the NIH ecosystem, providing specialized biological research materials and reagents that support translational science and biomedical research initiatives across multiple federal institutes and centers. The company's $10 million single-award BPA with the Office of Logistics and Acquisition Operations, effective through September 30, 2025, enables flexible fulfillment of task orders for biological materials, laboratory supplies, and specialized reagents supporting research domains including infectious diseases, cancer, and translational science. This particular task order exemplifies the company's ongoing role in supplying high-quality research proteins and conjugates essential to the federal research enterprise.
Quick answers
Who was awarded contract HHSN31900004?
HHSN31900004 was awarded to Research And Diagnostic Systems, Inc. by National Center for Advancing Translational Sciences (National Institutes of Health) on May 20, 2015.
How much is contract HHSN31900004 worth?
The government has obligated $13,204 on HHSN31900004.
Is contract HHSN31900004 an order under another contract?
Yes. HHSN31900004 is a BPA call under HHSN263199900050140B, a blanket purchase agreement.
Was contract HHSN31900004 competed?
The extent of competition for HHSN31900004 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award